Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

ClinicalTrials.gov ID: NCT06953869

Public ClinicalTrials.gov record NCT06953869. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 6:58 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Randomized Study to Evaluate the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a multicenter, double-blind, randomized study to evaluate the efficacy and safety of a daily single oral dose of tasimelteon and matching placebo in male and female pediatric participants with insomnia disorder.

Study identification

NCT ID
NCT06953869
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Vanda Pharmaceuticals
Industry
Enrollment
420 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
2 Years to 17 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 20, 2025
Primary completion
Oct 31, 2027
Completion
Dec 31, 2027
Last update posted
Jun 4, 2026

2025 – 2028

United States locations

U.S. sites
21
U.S. states
14
U.S. cities
20
Facility City State ZIP Site status
Vanda Investigational Site Dothan Alabama 36303 Recruiting
Vanda Investigational Site Phoenix Arizona 85006 Recruiting
Vanda Investigational Site Irvine California 92614 Recruiting
Vanda Investigational Site Miami Florida 33155 Recruiting
Vanda Investigational Site Miami Lakes Florida 33016 Recruiting
Vanda Investigational Site Winter Park Florida 32789 Recruiting
Vanda Investigational Site Snellville Georgia 30078 Recruiting
Vanda Investigational Site Stockbridge Georgia 30281 Recruiting
Vanda Investigational Site Naperville Illinois 60563 Recruiting
Vanda Investigational Site Worcester Massachusetts 01608 Recruiting
Vanda Investigational Site Great Falls Montana 59405 Recruiting
Vanda Investigational Site Lincoln Nebraska 68526 Active, not recruiting
Vanda Investigational Site Las Vegas Nevada 89128 Recruiting
Vanda Investigational Site Cleveland Ohio 11100 Recruiting
Vanda Investigational Site Columbia South Carolina 29201 Recruiting
Vanda Investigational Site Myrtle Beach South Carolina 29582 Recruiting
Vanda Investigational Site Nashville Tennessee 37232 Recruiting
Vanda Investigational Site Houston Texas 77030 Recruiting
Vanda Investigational Site Plano Texas 75075 Recruiting
Vanda Investigational Site San Antonio Texas 78229 Recruiting
Vanda Investigational Site San Antonio Texas 78249 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 14 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06953869, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 4, 2026 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06953869 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →